[{"address1": "2430 North Halsted Street", "city": "Chicago", "state": "IL", "zip": "60614", "country": "United States", "phone": "847 673 1700", "fax": "847 556 6411", "website": "https://www.exicuretx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Exicure, Inc. does not have significant operations. previously, the company focused on developing of nucleic acid therapies targeting ribonucleic acid against validated targets. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.", "fullTimeEmployees": 5, "companyOfficers": [{"maxAge": 1, "name": "Mr. Paul  Kang", "age": 61, "title": "CEO, President & Director", "yearBorn": 1962, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jiyoung  Hwang", "age": 46, "title": "CFO, Secretary & Director", "yearBorn": 1977, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Joshua  Miller", "age": 47, "title": "Chief Accounting Officer", "yearBorn": 1976, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 10, "boardRisk": 10, "compensationRisk": 10, "shareHolderRightsRisk": 7, "overallRisk": 10, "governanceEpochDate": 1717200000, "maxAge": 86400, "priceHint": 4, "previousClose": 0.33, "open": 0.3433, "dayLow": 0.321, "dayHigh": 0.3433, "regularMarketPreviousClose": 0.33, "regularMarketOpen": 0.3433, "regularMarketDayLow": 0.321, "regularMarketDayHigh": 0.3433, "beta": 1.278, "forwardPE": -0.42389613, "volume": 68470, "regularMarketVolume": 68470, "averageVolume": 312266, "averageVolume10days": 115800, "averageDailyVolume10Day": 115800, "marketCap": 2823735, "fiftyTwoWeekLow": 0.3, "fiftyTwoWeekHigh": 1.5, "priceToSalesTrailing12Months": 5.64747, "fiftyDayAverage": 0.47392, "twoHundredDayAverage": 0.593875, "currency": "USD", "enterpriseValue": 8951167, "floatShares": 7809910, "sharesOutstanding": 8651150, "sharesShort": 126462, "sharesShortPriorMonth": 151664, "sharesShortPreviousMonthDate": 1713139200, "dateShortInterest": 1715731200, "sharesPercentSharesOut": 0.0146, "heldPercentInsiders": 0.45023, "heldPercentInstitutions": 0.10305, "shortRatio": 3.59, "shortPercentOfFloat": 0.0168, "impliedSharesOutstanding": 8651150, "bookValue": 0.255, "priceToBook": 1.2800001, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -13336000, "trailingEps": -1.51, "forwardEps": -0.77, "lastSplitFactor": "1:30", "lastSplitDate": 1656547200, "enterpriseToRevenue": 17.902, "enterpriseToEbitda": -0.897, "52WeekChange": -0.7213675, "SandP52WeekChange": 0.2586832, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "XCUR", "underlyingSymbol": "XCUR", "shortName": "Exicure, Inc.", "longName": "Exicure, Inc.", "firstTradeDateEpochUtc": 1526995800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "ee4bcb27-f318-38c7-8572-459785e7d845", "messageBoardId": "finmb_82271676", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.3264, "recommendationMean": 3.0, "recommendationKey": "hold", "totalCash": 366000, "totalCashPerShare": 0.042, "ebitda": -9983000, "totalDebt": 6493000, "quickRatio": 0.138, "currentRatio": 0.55, "totalRevenue": 500000, "debtToEquity": 294.2, "revenuePerShare": 0.058, "returnOnAssets": -0.37416, "returnOnEquity": -1.58517, "freeCashflow": -4230125, "operatingCashflow": -7489000, "grossMargins": 1.0, "operatingMargins": -1.6719999, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-06-21"}]